| Total number of patients | 163 |
| Gender | Female |
| Age at diagnosis mean, (range) years | 63 (32 - 85) |
| Histology, n (%) | |
| Invasive ductal carcinoma | 129 (79%) |
| Invasive lobular carcinoma | 23 (14%) |
| Other | 11 (7%) |
| Tumor size, n (%) | |
| <20 mm | 89 (55%) |
| 20mm ≤ size < 50mm | 70 (43%) |
| ≥50mm | 4 (2%) |
| Malignancy grade, n (%) | |
| Grade 1 | 53 (32%) |
| Grade 2 | 58 (36%) |
| Grade 3 | 49 (30%) |
| Not graded | 3 (2%) |
| Estrogen receptor status, n (%) | |
| Positive | 142 (87%) |
| Negative | 21 (13%) |
| HER2 status, n (%) | |
| Normal expression | 126 (77%) |
| Overexpression | 15 (9%) |
| Unknown | 22 (14%) |
| Axillary lymph node status, n (%) | |
| Lymph node positive | 96 (59%) |
| Lymph node negative | 67 (41%) |